Abstract P143: Effects Of Oral Anticoagulant Choice On Mortality In The Primary Treatment Of Non-cancer Venous Thromboembolism: Medicare, 2011-2016

Introduction: Oral anticoagulants (OAC) are the mainstay of venous thromboembolism (VTE) treatment, with newer direct oral anticoagulants (DOACs; rivaroxaban, apixaban, and dabigatran) approved for...